Dollars and Digital: The Future of Pharma Finance

Pharm Exec convenes a panel of biopharma finance leaders to discuss the pace of digital technology adoption in accounting and reporting and the growing role and responsibility of finance teams in harnessing data and analytics to deliver deeper and more strategic insights across the organizatio Powered by WPeMatico Continue reading Dollars and Digital: The Future of Pharma Finance

It s Time for a Chief Adherence Officer

The pharma revenue engine is stalling. A full 78% of Americans, according to the Kaiser Health Tracking Poll , say drug companies making too much money is a major reason why their healthcare costs have been rising, up from 62% who felt that way in 2014. The political winds have shifted and Powered by WPeMatico Continue reading It s Time for a Chief Adherence Officer

Empowering Women Entrepreneurs in Healthcare

Advancements in technology are changing the face of healthcare and creating opportunities for entrepreneurship across the board. At the forefront of this transformation are woman-owned companies that are embracing innovation and making important contributions to fields like consulting, patient e Powered by WPeMatico Continue reading Empowering Women Entrepreneurs in Healthcare

Time is Running Out for Pharma to Change Course

Tom Kottler It s no surprise that pharmaceutical giants Pfizer and Merck raised drug prices once again. While the companies may take a bit of political heat now, they know that in the long run this approach will do what it has consistently done before. After all, why give up on the stra Powered by WPeMatico Continue reading Time is Running Out for Pharma to Change Course

8 Tipping Points: Pharm Exec s 2019 Industry Forecast

Welcome once again to Pharm Exec s annual look at what s ahead for the biopharma industry, where we hope the eight trends singled out for this year capture the pulse of change and opportunity impacting leaders and decision-makers in the life sciences the most. From technology and digital hea Powered by WPeMatico Continue reading 8 Tipping Points: Pharm Exec s 2019 Industry Forecast

Future Pharma: Data Science as a Strategic Partner

Leaders at Novartis share how the big pharma is laying the foundations for a potential new operating model as a “medicines and data science company” At the beginning of 2018, Novartis CEO Vas Narasimhan spoke of reimagining Novartis as a medicines and data science com Powered by WPeMatico Continue reading Future Pharma: Data Science as a Strategic Partner

Securing a Winning Strategy for Real-World Evidence

While the increasing importance of real-world evidence (RWE) is widely acknowledged, the dramatic shift required by biopharma companies to embed and secure an RWE capability effectively across the organization is still a work in progress In Deloitte s Second Annual Real-World Powered by WPeMatico Continue reading Securing a Winning Strategy for Real-World Evidence